Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
1234
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Pediatric Cancer 2017 NIAMS 5R21AR066938-02 Human artificial chromosome as vectors for gene therapy of a model skin disease MONACO, ZOIA TUFTS UNIVERSITY MEDFORD MA $208,548
Pediatric Cancer 2017 NCI 5R01CA158768-06 The Function of rpL5 and rpL11 in induction of p53 THOMAS, GEORGE FUNDACIO PRIVADA INT D'VEST BIOMEDICA SPAIN $224,100
Pediatric Cancer 2017 NCI 5R01CA181050-04 KIR-FAVORABLE HAPLOIDENTICAL TRANSPLANTATION IN CHILDREN PULSIPHER, MICHAEL CHILDREN'S HOSPITAL OF LOS ANGELES CA $90,772
Pediatric Cancer 2017 NCI 5R21CA187412-03 Impact of primary tumor development stage on prognosis and outcome in B-ALL CARLSON, CHRISTOPHER FRED HUTCHINSON CANCER RESEARCH CENTER WA $100,931
Pediatric Cancer 2017 NCI 5R01CA190980-03 Contribution of development and age to breast cancer etiology BARCELLOS-HOFF, MARY UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $501,556
Pediatric Cancer 2017 NIEHS 5U13ES026496-02 Childhood Leukemia International Consortium Scientific Annual Meetings METAYER, CATHERINE UNIVERSITY OF CALIFORNIA BERKELEY CA $15,000
Pediatric Cancer 2017 NINDS 7K08NS083626-03 Elucidating Signaling Pathways for GABA-A Receptor Alpha5 in an Aggressive Subtype of Medulloblastomas SENGUPTA, SOMA EMORY UNIVERSITY GA $182,201
Pediatric Cancer 2017 NINDS 1R01NS094218-01A1 Focal Sustained Release Chemotherapy-Loaded Biomaterials at Tumor Sites KAPLAN, DAVID TUFTS UNIVERSITY MEDFORD MA $355,019
Pediatric Cancer 2017 NCI 5R00CA178207-05 Genome instability and epigenetic deregulation in retinoblastoma and osteosarcoma BENAVENTE ARIAS, CLAUDIA UNIVERSITY OF CALIFORNIA-IRVINE CA $236,243
Pediatric Cancer 2017 NCI 5R01CA132640-16 Role of heat shock factors (Hsfs) in tumorigenesis MIVECHI, NAHID AUGUSTA UNIVERSITY GA $270,000
Pediatric Cancer 2017 NCI 5R01CA190964-03 Role of IKAROS in the Biology and Therapy of High-Risk Precursor B-Cell Leukemia VAN ETTEN, RICHARD UNIVERSITY OF CALIFORNIA-IRVINE CA $544,106
Pediatric Cancer 2017 NCI 5R01CA191077-03 Assay Development for NSD1 Methyltransferase Inhibitor Discovery KOLB, EDWARD ALFRED I. DU PONT HOSP FOR CHILDREN DE $312,244
Pediatric Cancer 2017 NCI 5R21CA195356-02 Role of ThPOK in HSC Maintenance and Leukemogenesis KAPPES, DIETMAR RESEARCH INST OF FOX CHASE CAN CTR PA $199,013
Pediatric Cancer 2017 NCI 5R21CA194829-03 Metabolic regulation of T-ALL cellular proliferation and lifespan RATHMELL, JEFFREY VANDERBILT UNIVERSITY MEDICAL CENTER TN $204,885
Pediatric Cancer 2017 NCI 5R03CA201540-02 Cognitive and Psychosocial Functioning of Children Treated for Retinoblastoma WILLARD, VICTORIA ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $89,750
Pediatric Cancer 2017 NCI 5R01CA190617-03 Itraconazole Analogues to Treat Medulloblastoma HADDEN, MATTHEW UNIVERSITY OF CONNECTICUT STORRS CT $382,472
Pediatric Cancer 2017 NCI 1R35CA197695-01A1 Translating genomic discoveries to improved outcomes for high risk acute leukemia MULLIGHAN, CHARLES ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $1,071,276
Pediatric Cancer 2017 NCI 5R01CA195519-02 Image-guided irradiation safely intensifies HSCT regimen for refractory leukemia FORMAN, STEPHEN BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $272,213
Pediatric Cancer 2017 NCI 5R01CA201184-02 Biologic and Therapeutic Significance of miR-155 in AML MARCUCCI, GUIDO BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $554,107
Pediatric Cancer 2017 NCI 5R21CA202210-02 Symptom progress and adverse health outcomes in adult childhood cancer survivors HUANG, I-CHAN ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $195,206
Pediatric Cancer 2017 NCI 5R01CA072669-20 Cytotoxic-T-Lymphocyte (CTL) Therapy of AML BLAZAR, BRUCE UNIVERSITY OF MINNESOTA MN $294,076
Pediatric Cancer 2017 NCI 5R03CA201953-02 Adolescent tanning and social media MORENO, MEGAN SEATTLE CHILDREN'S HOSPITAL WA $46,473
Pediatric Cancer 2017 NCI 5R01CA169784-04 Genetic Dissection of Acute Myeloid Leukemia. AIFANTIS, IANNIS NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $355,993
Pediatric Cancer 2017 NCI 5R01CA172408-04 Role of Asxl1 in normal hematopoiesis and pathogenesis of myeloid malignancies YANG, FENG-CHUN UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $318,513
Pediatric Cancer 2017 NCI 5R01CA174683-04 Comprehensive Approach to Improve Medicine Adherence in Pediatric Leukmia BHATIA, SMITA UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $606,475
Pediatric Cancer 2017 NCI 5R01CA182528-05 Potential therapeutic implications of targeting miR-150 in acute myeloid leukemia CHEN, JIANJUN UNIVERSITY OF CINCINNATI OH $336,114
Pediatric Cancer 2017 NCI 5R01CA178380-04 Leukotriene-Induced Nestin Expression Promotes Medulloblastoma Tumorigenesis YANG, ZENG-JIE RESEARCH INST OF FOX CHASE CAN CTR PA $379,725
Pediatric Cancer 2017 NCI 5R00CA181500-04 The Role of Protein Tyrosine Phosphate PRL3 in Leukemia Development BLACKBURN, JESSICA UNIVERSITY OF KENTUCKY KY $248,999
Pediatric Cancer 2017 NCI 5F31CA196330-02 Investigating the potential role of NADPH oxidase 2 in regulating the biology of leukemic stem cells ADANE, BINIAM UNIVERSITY OF COLORADO DENVER CO $29,728
Pediatric Cancer 2017 NHLBI 5R01HL117976-04 Epithelial mechanisms of inducible resistance to AML-associated pneumonia EVANS, SCOTT UNIVERSITY OF TX MD ANDERSON CAN CTR TX $400,000
Pediatric Cancer 2017 NCI 5R01CA167708-05 Targeting AML with PI3K/AKT inhibitors and BH3-mimetics GRANT, STEVEN VIRGINIA COMMONWEALTH UNIVERSITY VA $284,794
Pediatric Cancer 2017 NCI 5K07CA174728-04 A Novel Mobile Health Fitness Program for AYA Childhood Cancer Survivors DEVINE, KATIE RBHS -CANCER INSTITUTE OF NEW JERSEY NJ $164,851
Pediatric Cancer 2017 NCI 5R01CA194058-02 Painted erythrocyte carriers for therapy of acute myeloid leukemia SIMBERG, DIMITRI UNIVERSITY OF COLORADO DENVER CO $352,151
Pediatric Cancer 2017 NCI 5R21CA191818-02 Proton minibeams: Overcoming proton beams’ inability to spare superficial tissues KRISHNAN, SUNIL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $174,395
Pediatric Cancer 2017 NCI 5R01CA185301-03 Enhancing NK Cell Activity by Dietary Diphyllin Lignans for Cancer Prevention CALIGIURI, MICHAEL OHIO STATE UNIVERSITY OH $352,275
Pediatric Cancer 2017 NCI 5R01CA201230-02 The role of H3K79 methylation in IDH-mutant leukemia BERNT, KATHRIN UNIVERSITY OF COLORADO DENVER CO $10,000
Pediatric Cancer 2017 NCI 5R01CA090668-14 FLT3 Tyrosine Kinase Inhibitors as Therapy for Leukemia SMALL, DONALD JOHNS HOPKINS UNIVERSITY MD $291,600
Pediatric Cancer 2017 NCI 5R21CA187548-02 Second generation MIBG analogs that cotarget DNA for high risk neuroblastoma BARANOWSKA-KORTYLEWICZ, JANINA UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $163,669
Pediatric Cancer 2017 NCI 5R01CA118332-10 Parent-Child Communication About Cancer COMPAS, BRUCE VANDERBILT UNIVERSITY TN $437,647
Pediatric Cancer 2017 NCI 5R01CA142665-07 Glucocorticoids in Lymphoblastic Leukemia RELLING, MARY ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $487,994
Pediatric Cancer 2017 NIGMS 5R01GM117093-02 Kinase-mediated assembly of the mRNA entry channel in 40S ribosomes KARBSTEIN, KATRIN SCRIPPS FLORIDA FL $416,481
Pediatric Cancer 2017 NICHD 5R01HD086195-02 Smart targeting nano-theranostics for image-guided drug delivery to pediatric brain tumors LI, YUANPEI UNIVERSITY OF CALIFORNIA AT DAVIS CA $325,775
Pediatric Cancer 2017 NCI 5R01CA080728-17 Dissection of eIF4E dependent mRNA export BORDEN, KATHERINE UNIVERSITY OF MONTREAL CANADA $210,799
Pediatric Cancer 2017 NCI 5R21CA191989-02 Work Ability in Young Adult Surviviors (WAYS): A Quantitative Investigation DANHAUER, SUZANNE WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $168,563
Pediatric Cancer 2017 NCI 5K08CA181340-04 Targeting Chromatin Modifications in Leukemia with Trisomy 21 LANE, ANDREW DANA-FARBER CANCER INST MA $155,991
Pediatric Cancer 2017 NCI 5P30CA014236-43 5328 Neuro-Oncology Research Program KASTAN, MICHAEL DUKE UNIVERSITY NC $41,908
Pediatric Cancer 2017 NHLBI 5R01HL130034-02 The Cebpa Enhancer in Normal Hematopoiesis and Progression to AML FRIEDMAN, ALAN JOHNS HOPKINS UNIVERSITY MD $405,000
Pediatric Cancer 2017 NCI 5P01CA094237-15 7520 VACCINATION TO ENHANCE T CELL IMMUNOTHERAPY HESLOP, HELEN BAYLOR COLLEGE OF MEDICINE TX $295,519
Pediatric Cancer 2017 NCI 5P01CA094237-15 7530 CHIMERIC T CELLS TARGETING NEUROBLASTOMA HESLOP, HELEN BAYLOR COLLEGE OF MEDICINE TX $295,506
Pediatric Cancer 2017 NCI 5R43CA203351-02 Phase I Clinical trial with 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Children with Cancer Involving the CNS MORGAN, LEE DEKK-TEC, INC. LA $90,362
Pediatric Cancer 2017 NCI 5R01CA187219-02 Peptide vaccine immunotherapy for children with recurrent low-grade astrocytomas POLLACK, IAN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $356,618
Pediatric Cancer 2017 NCI 5P30CA023108-38 5364 Protocol Review and Monitoring (PRMS) LEWIS, LIONEL DARTMOUTH COLLEGE NH $63,931
Pediatric Cancer 2017 NCI 5P30CA008748-51 7572 Research Pharmacy MULLER, RAYMOND SLOAN-KETTERING INST CAN RESEARCH NY $239,419
Pediatric Cancer 2017 NCI 5F30CA183507-04 Cytotoxicity of MLN4924 in Acute Myeloid Leukemia KNORR, KATHERINE MAYO CLINIC ROCHESTER MN $23,878
Pediatric Cancer 2017 NCI 5R01CA172398-05 The role of ETV6 in T-cell acute lymphoblastic leukemia FERRANDO, ADOLFO COLUMBIA UNIVERSITY HEALTH SCIENCES NY $332,000
Pediatric Cancer 2017 NCI 5R21CA183623-03 Pediatric Cancer Salvia Biorepository GRAHAM, DAVID JOHNS HOPKINS UNIVERSITY MD $245,885
Pediatric Cancer 2017 NCI 5R01CA173636-05 Role of TET2 mutations in malignant transformation and acute myeloid leukemia LEVINE, ROSS SLOAN-KETTERING INST CAN RESEARCH NY $639,626
Pediatric Cancer 2017 NCI 5F30CA183497-04 Modeling Transformation: Myeloproliferative Neoplasms to Acute Myeloid Leukemia MCKENNEY, ANNA WEILL MEDICAL COLL OF CORNELL UNIV NY $49,044
Pediatric Cancer 2017 NCI 5R01CA172268-05 The role of inhibitory receptors in leukemia development ZHANG, CHENGCHENG UT SOUTHWESTERN MEDICAL CENTER TX $329,925
Pediatric Cancer 2017 NCI 5R01CA201225-02 Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell Immunotherapy ARMISTEAD, PAUL UNIV OF NORTH CAROLINA CHAPEL HILL NC $500,397
Pediatric Cancer 2017 NCI 2P30CA006516-52 5399 Program 4: Leukemia EBERT, BENJAMIN BRIGHAM AND WOMEN'S HOSPITAL MA $43,922
Pediatric Cancer 2017 NCI 2P30CA006516-52 5409 Program 30: Neuro-Oncology STILES, CHARLES DANA-FARBER CANCER INST MA $42,805
Pediatric Cancer 2017 NCI 1R01CA211044-01 Off-the-shelf engineered NK cells for the treatment of AML REZVANI, KATY UNIVERSITY OF TX MD ANDERSON CAN CTR TX $366,000
Pediatric Cancer 2017 NCI 5R01CA164024-05 Identifying Cell Stress Proteins that Predict Clinical Response in Pediatric AML HORTON, TERZAH BAYLOR COLLEGE OF MEDICINE TX $319,474
Pediatric Cancer 2017 NCI 5R01CA172392-05 Mechanisms of PPM1D in medulloblastoma tumorigenesis and invasion CASTELLINO, ROBERT EMORY UNIVERSITY GA $323,700
Pediatric Cancer 2017 NCI 5F31CA192822-03 Differential Regulation of PI3KC2beta by Ras Protooncogenes In Acute Myeloid Leukemia SMITH, RUSSELL UNIVERSITY OF ILLINOIS AT CHICAGO IL $23,996
Pediatric Cancer 2017 NCI 2U24CA055727-23 Childhood Cancer Survivor Study ARMSTRONG, GREGORY ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $3,616,741
Pediatric Cancer 2017 NINDS 5R01NS088219-03 Glycolytic regulation of cerebellar development and medulloblastoma tumorigenesis GERSHON, TIMOTHY UNIV OF NORTH CAROLINA CHAPEL HILL NC $327,837
Pediatric Cancer 2017 NIAID 5R01AI018757-35 Host Immunity to EBV Infection in Vitro and in Vivo THORLEY-LAWSON, DAVID TUFTS UNIVERSITY BOSTON MA $412,500
Pediatric Cancer 2017 NICHD 5R01HD079568-03 MICROBLEEDS AS A MARKER OF RADIATION-INDUCED BRAIN INJURY IN PEDIATRIC PATIENTS LUPO, JANINE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $499,938
Pediatric Cancer 2017 NCI 5P01CA084203-13 5337 Project 1: Small Molecule Enhancers of Photodynamic Therapy for Skin Cancer MAYTIN, EDWARD MASSACHUSETTS GENERAL HOSPITAL MA $180,974
Pediatric Cancer 2017 NINDS 5R01NS096236-02 Targeting mechanisms of medulloblastoma formation VAN MEIR, ERWIN EMORY UNIVERSITY GA $386,460
Pediatric Cancer 2017 NCI 1R01CA211614-01 Targeting TET1 signaling to treat acute myeloid leukemia CHEN, JIANJUN UNIVERSITY OF CINCINNATI OH $430,865
Pediatric Cancer 2017 NCI 1R01CA211328-01 Regulation of the LIN28/let-7 pathway in cancer GREGORY, RICHARD BOSTON CHILDREN'S HOSPITAL MA $404,888
Pediatric Cancer 2017 NHLBI 5R01HL117737-18 Microchimerism as AlloImmunity NELSON, J. FRED HUTCHINSON CANCER RESEARCH CENTER WA $477,844
Pediatric Cancer 2017 NCI 1R01CA211963-01 Ionizing radiation induced hematological malignancies ZHOU, DAOHONG UNIV OF ARKANSAS FOR MED SCIS AR $355,340
Pediatric Cancer 2017 NCI 1R01CA211711-01 APPLYING ERROR-CORRECTED SEQUENCING TO DETECT MINIMAL RESIDUAL IN THE AAML 1031 STUDY DRULEY, TODD WASHINGTON UNIVERSITY MO $388,615
Pediatric Cancer 2017 NCI 5R01CA132685-10 Molecular Mechanisms Regulating the Retinoblastoma Protein Family RUBIN, SETH UNIVERSITY OF CALIFORNIA SANTA CRUZ CA $342,389
Pediatric Cancer 2017 NINR 1R01NR016720-01 PediQUEST: Improving Children's Quality of Life through e-PROMS and Palliative Care WOLFE, JOANNE DANA-FARBER CANCER INST MA $565,742
Pediatric Cancer 2017 NCI 1R01CA212649-01 Personalized vaccine for patients with AML AVIGAN, DAVID BETH ISRAEL DEACONESS MEDICAL CENTER MA $739,429
Pediatric Cancer 2017 NCI 1R01CA211996-01 Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy CHOW, ERIC FRED HUTCHINSON CANCER RESEARCH CENTER WA $742,626
Pediatric Cancer 2017 NCI 1R01CA213131-01 Targeting Transcriptional Regulators for Immunotherapy of Acute Myeloid Leukemia KORTYLEWSKI, MARCIN BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $428,441
Pediatric Cancer 2017 NCI 1R01CA213138-01 CD25-mediated feedback control of BCR-signaling and its oncogenic mimics MÜSCHEN, MARKUS BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $395,738
Pediatric Cancer 2017 NCI 1R01CA204093-01A1 A First-in-Human Pilot Study of 18F-MFBG Imaging for Evaluation of Neuroblastoma PANDIT-TASKAR, NEETA SLOAN-KETTERING INST CAN RESEARCH NY $392,078
Pediatric Cancer 2017 NINDS 5R01NS096368-02 Regulation of Medulloblastoma Metastasis by Emp1 WECHSLER-REYA, ROBERT SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $426,563
Pediatric Cancer 2017 NIEHS 1R21ES027418-01 Training Pediatric Health Care Providers as a Primary Information Source for Communicating Environmental Risks for Breast Cancer SILK, KAMI MICHIGAN STATE UNIVERSITY MI $228,277
Pediatric Cancer 2017 NCI 5R01CA192924-03 CSF2 receptor mediated actions in t(8;21) leukemia ZHANG, DONG-ER UNIVERSITY OF CALIFORNIA SAN DIEGO CA $343,706
Pediatric Cancer 2017 NCI 5R01CA142874-07 Targeting PML for Leukemia Therapy PANDOLFI, PIER PAOLO BETH ISRAEL DEACONESS MEDICAL CENTER MA $465,791
Pediatric Cancer 2017 NCI 5R01CA172040-05 Microenvironment-Leukemia Communication Through Lectins HEISTERKAMP, NORA CHILDREN'S HOSPITAL OF LOS ANGELES CA $336,150
Pediatric Cancer 2017 NIDDK 5R01DK105014-03 Role of the Hypoxia-Inducible Factor-1alpha in Myelodysplastic Syndromes HUANG, GANG CINCINNATI CHILDRENS HOSP MED CTR OH $351,000
Pediatric Cancer 2017 NINDS 1K08NS099427-01 Targeting ATRX-Deficient Pediatric GBM KOSCHMANN, CARL UNIVERSITY OF MICHIGAN MI $163,263
Pediatric Cancer 2017 NHLBI 1K08HL135434-01 Targeting SETBP1 in Myeloproliferative Disorders STIEGLITZ, ELLIOT UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $179,928
Pediatric Cancer 2017 NEI 1K08EY027464-01 Developing alternative approaches to reduce retinal toxicity and prevent vision loss in the treatment of intraocular retinoblastoma DANIELS, ANTHONY VANDERBILT UNIVERSITY MEDICAL CENTER TN $191,925
Pediatric Cancer 2017 NCI 1K08CA212279-01 Understanding How Ciliary Hedgehog Signaling Causes Medulloblastoma RALEIGH, DAVID UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $177,124
Pediatric Cancer 2017 NICHD 1R21HD090503-01 Drug delivery system for enhancing radiation therapy in pediatric glioma SALTZMAN, W YALE UNIVERSITY CT $251,250
Pediatric Cancer 2017 NCI 5R01CA084628-25 Telomerase in Development, Senescence and Neoplasia DEPINHO, RONALD UNIVERSITY OF TX MD ANDERSON CAN CTR TX $616,000
Pediatric Cancer 2017 NCI 5R01CA157460-06 Nonadherence: Undermining health outcomes in pediatric HSCT? PAI, AHNA CINCINNATI CHILDRENS HOSP MED CTR OH $269,433
Pediatric Cancer 2017 NCI 5R01CA174794-05 Brain Integrity in Survivors of Childhood Cancer Treated with Thoracic Radiation KRULL, KEVIN ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $605,760
Pediatric Cancer 2017 NCI 5F30CA186466-03 Role of GSK3beta Subcellular Localization in AML Stemness IGNATZ-HOOVER, JAMES CASE WESTERN RESERVE UNIVERSITY OH $29,040
Pediatric Cancer 2017 NCI 5R01CA166280-05 Therapeutic Targeting of Leukemia-Microenvironmental Interactions CALVI, LAURA UNIVERSITY OF ROCHESTER NY $318,513
Pediatric Cancer 2017 NCI 5P30CA021765-38 6700 Cancer Prevention & Control GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $588,586
Pediatric Cancer 2017 NCI 5P30CA021765-38 6701 Developmental Biology and Solid Tumor GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $987,654
Pediatric Cancer 2017 NCI 5P30CA021765-38 6702 Hematalogical Malignancies GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $695,188
Pediatric Cancer 2017 NCI 5P30CA021765-38 6703 Neurobiology and Brain Tumors GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $325,816
Pediatric Cancer 2017 NCI 5P30CA021765-38 6704 Shared Resource Group1: Genomics and Statistics GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $188,781
Pediatric Cancer 2017 NCI 5P30CA021765-38 6707 Data and Safety Monitoring/NIH Policy GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $153,117
Pediatric Cancer 2017 NCI 5P30CA021765-38 6709 Early Phase Clinical Research Support GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $256,191
Pediatric Cancer 2017 NCI 5P30CA021765-38 6710 Senior Leadership GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $371,956
Pediatric Cancer 2017 NCI 5P30CA021765-38 6711 Planning and Evaluation GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $75,223
Pediatric Cancer 2017 NCI 5P30CA021765-38 6713 Administration GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $258,156
Pediatric Cancer 2017 NCI 5P30CA021765-38 6716 Transdisciplinary Collaboration and Coordination GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $319,535
Pediatric Cancer 2017 NCI 5R01CA194057-03 Metabolic pathways in leukemia SCHUETZ, JOHN ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $410,606
Pediatric Cancer 2017 NCI 5R01CA195642-03 Triad1 regulates myelopoiesis and functions as a leukemia suppressor EKLUND, ELIZABETH NORTHWESTERN UNIVERSITY AT CHICAGO IL $353,419
Pediatric Cancer 2017 NCI 5R01CA076167-14 Genetic Analysis of Myeloproliferative Disease COWELL, JOHN AUGUSTA UNIVERSITY GA $307,800
Pediatric Cancer 2017 NCI 5R01CA183874-03 Mechanism of tumor promotion by the H3K9 histone demethylase KDM3A in Ewing Sarcoma. JEDLICKA, PAUL UNIVERSITY OF COLORADO DENVER CO $355,706
Pediatric Cancer 2017 NIBIB 5R01EB020613-02 Rapid MRI acquisition for pediatric low-grade gliomas SETSOMPOP, KAWIN MASSACHUSETTS GENERAL HOSPITAL MA $651,546
Pediatric Cancer 2017 NIAID 5U01AI104342-05 Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children ESQUIVEL, CARLOS STANFORD UNIVERSITY CA $1,363,549
Pediatric Cancer 2017 NCI 1R15CA206051-01A1 Developing Therapeutic Strategies for Histone H3.3 Mutant Tumors via Rational Targeting of Specific DNA Repair Pathways GUNJAN, AKASH FLORIDA STATE UNIVERSITY FL $429,583
Pediatric Cancer 2017 NCI 1R03CA212800-01 Advancing Treatments for Pediatric Craniopharyngioma (ATPC): Preliminary Assessment of the Cyst Fluid Inflammatory Milieu HANKINSON, TODD UNIVERSITY OF COLORADO DENVER CO $77,750
Pediatric Cancer 2017 NCI 5R01CA188520-03 Genome maintenance by Hdacs1,2 and their inhibition for Pre-B leukemia therapy BHASKARA, SRIVIDYA UNIVERSITY OF UTAH UT $340,838
Pediatric Cancer 2017 NINDS 5R21NS096502-02 Elucidating the drivers of medulloblastoma initiation and recurrence ROBBINS, DAVID UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $191,875
Pediatric Cancer 2017 NCI 1R03CA212924-01 Developing a Decision Aid for Adolescent and Young Adult Female Cancer Survivors Considering Future Family-Building after Treatment BENEDICT, CATHERINE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH NY $82,500
Pediatric Cancer 2017 NCI 5P30CA014089-42 5249 Core-007 GRUBER, STEPHEN UNIVERSITY OF SOUTHERN CALIFORNIA CA $498,596
Pediatric Cancer 2017 NCI 5P30CA014089-42 5251 Core-009 GRUBER, STEPHEN UNIVERSITY OF SOUTHERN CALIFORNIA CA $570,611
Pediatric Cancer 2017 NCI 5R00CA181496-04 Modeling p53 Mutant-Associated Cancer With LFS Patient-Derived iPSCs LEE, DUNG-FANG UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $243,144
Pediatric Cancer 2017 NCI 1R01CA204044-01A1 Regulation of TAL1/SCL in T-Cell Leukemia HUANG, SUMING UNIVERSITY OF FLORIDA FL $350,674
Pediatric Cancer 2017 NCI 5R01CA166429-06 Role of a Novel Homeobox Transcription Factor (HLX) in Acute Myeloid Leukemia STEIDL, ULRICH ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $384,342
Pediatric Cancer 2017 NCI 5R01CA170249-05 PKA and follicular thyroid carcinogenesis: Roles of interacting pathways KIRSCHNER, LAWRENCE OHIO STATE UNIVERSITY OH $316,438
Pediatric Cancer 2017 NIGMS 1R01GM118578-01A1 Genetics-guided Individualization of Thiopurine Therapy YANG, JUN ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $579,917
Pediatric Cancer 2017 NCI 5R01CA193677-02 Role of enhancer elements in regulating prometastatic transcriptional programs in osteosarcoma SCACHERI, PETER CASE WESTERN RESERVE UNIVERSITY OH $362,569
Pediatric Cancer 2017 NCI 1R01CA204158-01A1 Vitamin D and Photodynamic Therapy for Human Skin Cancer (SCC and BCC) MAYTIN, EDWARD CLEVELAND CLINIC LERNER COM-CWRU OH $490,760
Pediatric Cancer 2017 NCI 5F31CA203053-02 The histone demethylase KDM3A upregulates MCAM to promote Ewing Sarcoma metastasis SECHLER, MARYBETH UNIVERSITY OF COLORADO DENVER CO $13,205
Pediatric Cancer 2017 NCI 5R01CA172387-05 Polysomy 21 in Acute Lymphoblastic Leukemia WEINSTOCK, DAVID DANA-FARBER CANCER INST MA $352,946
Pediatric Cancer 2017 NCI 5R01CA174793-05 BET bromodomain inhibition as targeted therapy in acute myeloid leukemia VAKOC, CHRISTOPHER COLD SPRING HARBOR LABORATORY NY $557,762
Pediatric Cancer 2017 NCI 5R21CA194871-02 Role of EMSY protein complexes in the FA DNA repair pathway SOBECK, ALEXANDRA UNIVERSITY OF MINNESOTA MN $162,828
Pediatric Cancer 2017 NCI 1R01CA204258-01A1 Clinical Pregnancy Outcomes in Adolescent and Young Adult Female Cancer Survivors NICHOLS, HAZEL UNIV OF NORTH CAROLINA CHAPEL HILL NC $675,579
Pediatric Cancer 2017 NCI 2R01CA154923-06A1 Genetics of Rhabdomyosarcoma LANGENAU, DAVID MASSACHUSETTS GENERAL HOSPITAL MA $406,125
Pediatric Cancer 2017 NCI 1R01CA202261-01A1 Improving HPV Vaccination Delivery in Pediatric Primary Care: The STOP-HPV Trial SZILAGYI, PETER UNIVERSITY OF CALIFORNIA LOS ANGELES CA $676,337
Pediatric Cancer 2017 NCI 5R01CA180692-03 Role of LMO1 in Neuroblastoma Initiation and Maintenance MARIS, JOHN CHILDREN'S HOSP OF PHILADELPHIA PA $606,838
Pediatric Cancer 2017 NCI 5R01CA197336-02 Transcriptional CDKs as therapeutic targets in MYC-dependent cancers GEORGE, RANI DANA-FARBER CANCER INST MA $407,748
Pediatric Cancer 2017 NCI 5R01CA190843-03 A Label-Free, Point-of-Care Platform to Diagnose Acute Promyelocytic Leukemia SOHN, LYDIA UNIVERSITY OF CALIFORNIA BERKELEY CA $311,458
Pediatric Cancer 2017 NCI 5K08CA194162-03 The Role of LIN28B Signaling in Mediating the Oncogenic Phenotype in Neuroblas SCHNEPP, ROBERT EMORY UNIVERSITY GA $168,264
Pediatric Cancer 2017 NCI 1R01CA204915-01A1 Dissecting the Pathogenesis of Ewing Sarcoma with Integrative Genomics STEGMAIER, KIMBERLY DANA-FARBER CANCER INST MA $396,547
Pediatric Cancer 2017 NCI 1R01CA204979-01A1 Mechanisms of inv(16) acute myeloid leukemia CASTILLA, LUCIO UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $426,803
Pediatric Cancer 2017 NCI 2R01CA158073-06A1 The Role of ATM in Suppression of Lymphomas ZHA, SHAN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $380,000
Pediatric Cancer 2017 NCI 1R01CA204378-01A1 Improving treatment of cardiovascular risk factors in childhood cancer survivors CHOW, ERIC FRED HUTCHINSON CANCER RESEARCH CENTER WA $773,174
Pediatric Cancer 2017 NCI 2R01CA159859-06 Mouse models to discover new drivers of medulloblastoma WECHSLER-REYA, ROBERT SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $794,344
Pediatric Cancer 2017 NCI 5R01CA193842-03 Characterizing MSI2 in leukemia KHARAS, MICHAEL SLOAN-KETTERING INST CAN RESEARCH NY $414,827
Pediatric Cancer 2017 NCI 5R01CA187004-03 Targeting MLL3 histone methyltransferase DOU, YALI UNIVERSITY OF MICHIGAN MI $354,563
Pediatric Cancer 2017 NCI 5R21CA205912-02 Mediator Kinases and AML Cell Proliferation TAATJES, DYLAN UNIVERSITY OF COLORADO CO $172,855
Pediatric Cancer 2017 NCI 5R01CA178454-05 The role and functional mechanism of TET1 in MLL-rearranged leukemia CHEN, JIANJUN UNIVERSITY OF CINCINNATI OH $327,850
Pediatric Cancer 2017 NCI 5R01CA163452-05 Novel lysine deacetylase 6 Hsp domain inhibitors against AML CHOU, CHUNG-JEN JAMES MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $310,213
Pediatric Cancer 2017 NCI 1K08CA201591-01A1 Targeting the ARHGAP25 pathway in acute myelogenous leukemia stem cells WANG, LEO BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $169,560
Pediatric Cancer 2017 NCI 5R01CA151898-07 CRLF2 signaling in B-cell acute lymphoblastic leukemia WEINSTOCK, DAVID DANA-FARBER CANCER INST MA $392,969
Pediatric Cancer 2017 NCI 5R01CA176091-05 Crenolanib and ponatinib for the treatment of FLT3 mutant AML SHAH, NEIL UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $328,888
Pediatric Cancer 2017 NCI 5R01CA201496-02 Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia ROSEN, STEVEN BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $463,530
Pediatric Cancer 2017 NICHD 1R21HD087760-01A1 Targeting SHP2 phosphatase for chemoprevention of leukemic progression in Noonan syndrome QU, CHENG-KUI EMORY UNIVERSITY GA $195,000
Pediatric Cancer 2017 NCI 5R21CA195324-02 Targeting insulin receptor splicing for treatment of rhabdomyosarcoma CHANDLER, DAWN RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $164,349
Pediatric Cancer 2017 NIMHD 5R01MD007801-04 Reducing racial/ethnic inequities in childhood cancer survivorship MILAM, JOEL UNIVERSITY OF SOUTHERN CALIFORNIA CA $412,142
Pediatric Cancer 2017 NCI 5R01CA204308-02 Modulating signaling pathways in endothelial cells to abate leukemic progression. BUTLER, JASON WEILL MEDICAL COLL OF CORNELL UNIV NY $383,445
Pediatric Cancer 2017 NCI 5U01CA176063-04 ARID5B and disparities of childhood leukemia YANG, JUN ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $368,510
Pediatric Cancer 2017 NCI 5R01CA193235-03 Metabolic Regulation in Leukemia-Initatiating Cells NAKADA, DAISUKE BAYLOR COLLEGE OF MEDICINE TX $462,191
Pediatric Cancer 2017 NCI 5R01CA177810-03 Modulation of MicroRNAs with Xenobiotics to Target c-Myc LI, YONG CLEVELAND CLINIC LERNER COM-CWRU OH $368,974
Pediatric Cancer 2017 NCI 5R01CA197903-02 Molecular Characteristics of Treatment-resistant High-risk Neuroblastoma ZHONG, JOHN UNIVERSITY OF SOUTHERN CALIFORNIA CA $378,357
Pediatric Cancer 2017 NCI 5R21CA197441-02 Unraveling the Function of RNA-Binding proteins in B-lympoblastic Leukemia RAO, DINESH UNIVERSITY OF CALIFORNIA LOS ANGELES CA $200,970
Pediatric Cancer 2017 NCI 5F32CA206418-02 Epigenetic Mechanisms of Oncohistone Detoxification DIEHL, KATHARINE PRINCETON UNIVERSITY NJ $56,694
Pediatric Cancer 2017 NIGMS 5R01GM113100-03 Gli1-selective inhibitors of the Hedgehog signaling pathway CHEN, JAMES STANFORD UNIVERSITY CA $350,738
Pediatric Cancer 2017 NCI 5K99CA197498-03 Epigenetic mechanisms for oncogene silencing in MLL-rearranged leukemia CHEN, CHUN-WEI DANA-FARBER CANCER INST MA $154,058
Pediatric Cancer 2017 NCI 5R01CA171338-05 Novel Targeted Therapy for AML BHALLA, KAPIL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $332,000
Pediatric Cancer 2017 NCI 5R01CA181231-02 A high content screen dissecting ciliogenesis and oncogenic Hedgehog signaling REITER, JEREMY UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $362,569
Pediatric Cancer 2017 NCI 5K99CA197484-02 Identification of novel cooperating partners of MYCN in neuroblastoma tumorigenesis HUANG, MILLER UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $160,773
Pediatric Cancer 2017 NINDS 5R01NS091219-03 Targeting Wee1 in Myc driven Medulloblasoma VIBHAKAR, RAJEEV UNIVERSITY OF COLORADO DENVER CO $255,118
Pediatric Cancer 2017 NCI 5R01CA166025-05 Molecular Basis of Familial Paraganglioma MAHER, LOUIS MAYO CLINIC ROCHESTER MN $296,933
Pediatric Cancer 2017 NCI 5UM1CA183730-04 Collaborative Human Tissue Network (CHTN) RAMIREZ, NILSA RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $774,914
Pediatric Cancer 2017 NCI 5R01CA190661-02 Novel Biomarkers to Risk-Stratify AML Patients with NPM1^Pos/FLT3-IT^Neg Genotype STIREWALT, DEREK FRED HUTCHINSON CANCER RESEARCH CENTER WA $573,343
Pediatric Cancer 2017 NCI 5U10CA180866-04 Network Lead Academic Participating Site Grant from the Roswell Cancer Inst. LEVINE, ELLIS ROSWELL PARK CANCER INSTITUTE CORP NY $585,200
Pediatric Cancer 2017 NCI 5R21CA205936-02 SIRT5 as a Therapeutic Target in Acute Myeloid Leukemia DEININGER, MICHAEL UNIVERSITY OF UTAH UT $164,620
Pediatric Cancer 2017 NCI 5R01CA172067-06 Optimizing 131I-mIBG Therapy for Children with Advanced Neuroblastoma DUBOIS, STEVEN DANA-FARBER CANCER INST MA $363,425
Pediatric Cancer 2017 NCI 5R21CA205644-02 (PQ11) Reversing exosome-mediated immune suppression - a novel strategy for cancer therapy WHITESIDE, THERESA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $202,439
Pediatric Cancer 2017 NCI 5R01CA206210-02 Therapeutic targeting of glutamine metabolism in MDS KONOPLEVA, MARINA UNIVERSITY OF TX MD ANDERSON CAN CTR TX $474,750
Pediatric Cancer 2017 NCI 5UM1CA081457-19 Pediatric Brain Tumor Consortium (PBTC) ONAR-THOMAS, ARZU ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $2,728,300
Pediatric Cancer 2017 NCI 5R01CA116548-12 THE INITIATION AND REGULATION OF INFLAMMATION IN NEUROBLASTOMA METELITSA, LEONID BAYLOR COLLEGE OF MEDICINE TX $249,637
Pediatric Cancer 2017 NCI 5R01CA196851-02 Targeting vismodegib-resistant tumors using BH3 mimetics KIM, JAMES UT SOUTHWESTERN MEDICAL CENTER TX $346,985
Pediatric Cancer 2017 NCI 5U10CA180899-04 Children's Oncology Group Statistics and Data Center DEVIDAS, MEENAKSHI UNIVERSITY OF FLORIDA FL $7,008,867
Pediatric Cancer 2017 NCI 5R03CA186910-02 Parenting in the Face of Cancer: Non-Ill Sibling and Parent Relationships WALKER, AMY UNIVERSITY OF WASHINGTON WA $77,250
Pediatric Cancer 2017 NCI 5R01CA173852-04 Role of p21 activated kinase in Leukemogenesis KAPUR, REUBEN INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $323,700
Pediatric Cancer 2017 NCI 5R21CA190196-02 Imaging Tumor Associated Macrophages in Bone Sarcomas DALDRUP-LINK, HEIKE STANFORD UNIVERSITY CA $206,204
Pediatric Cancer 2017 NCI 5U24CA196173-03 COG Biospecimen Bank RAMIREZ MILAN, NILSA RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $2,244,903
Pediatric Cancer 2017 NCI 5R01CA192176-02 Developmental studies to inform clinical stratification and targeting of SHH MB JOYNER, ALEXANDRA SLOAN-KETTERING INST CAN RESEARCH NY $449,790
Pediatric Cancer 2017 NCI 5R33CA191143-03 Single cell growth assay for residual cells in acute lymphoblastic leukemia MANALIS, SCOTT MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $450,496
Pediatric Cancer 2017 NICHD 5R01HD081123-03 Personalized Whole Body Staging for Children with Cancer: A Solution to the Conundrum of Long-Term Side Effects from CT and PET/CT Scans DALDRUP-LINK, HEIKE STANFORD UNIVERSITY CA $492,552
Pediatric Cancer 2017 NCI 5R01CA175231-05 Reducing Skin Cancer Risk in Childhood Cancer Survivors GELLER, ALAN HARVARD SCHOOL OF PUBLIC HEALTH MA $643,350
Pediatric Cancer 2017 NCI 5P30CA013148-45 8603 04 Neuro-Oncology Program GILLESPIE, G. UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $108,080
Pediatric Cancer 2017 NCI 5R01CA204586-02 Yap and beta-catenin interactions in liver: Implications in Pathophysiology MONGA, SATDARSHAN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $414,072
Pediatric Cancer 2017 NCI 5K08CA204734-02 Determining the Role of BCOR Mutations in Myeloid Malignancies LINDSLEY, ROBERT DANA-FARBER CANCER INST MA $176,970
Pediatric Cancer 2017 NCI 1R41CA213690-01 AML-MutationCounter, a tool to detect residual and recurrent leukemia KAUFMANN, WILLIAM ASYSTBIO LABORATORIES, LLC NC $220,087
Pediatric Cancer 2017 NCI 1R44CA213595-01 Rapid detection of minimal residual disease in acute myeloid leukemia from peripheral blood MULLER, ROLF BIOFLUIDICA, INC NC $798,225
Pediatric Cancer 2017 NINDS 5R01NS088355-03 Targeting BET-bromodomains in neuroblastoma WEISS, WILLIAM UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $675,172
Pediatric Cancer 2017 NCI 5R01CA102031-12 Pharmacological modulation of epigenetic changes in AML MARCUCCI, GUIDO BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $342,107
Pediatric Cancer 2017 NCI 5R01CA166749-06 The Role of Growth Factor Receptor Trafficking in Tumorigenesis ZAGE, PETER UNIVERSITY OF CALIFORNIA SAN DIEGO CA $315,213
Pediatric Cancer 2017 NCI 5R01CA175216-02 Testicular effects of modern chemotherapy regimens in osteosarcoma survivors SHNORHAVORIAN, MARGARETT SEATTLE CHILDREN'S HOSPITAL WA $644,375
Pediatric Cancer 2017 NIDDK 5R01DK061470-14 Surgical Studies on the Role on Gastrin-releasing Peptide in Neuroblastoma CHUNG, DAI VANDERBILT UNIVERSITY MEDICAL CENTER TN $409,278
Pediatric Cancer 2017 NCI 1F30CA213878-01 Co-Evolution of the CD8+ T Cell Repertoire and AML In the Setting of Immunotherapy GEORGE, JASON RICE UNIVERSITY TX $49,044
Pediatric Cancer 2017 NCI 1F31CA213926-01 Omics Approach to Interrogating Mechanism of ETV5 in Glioma PARK, HANNAH CEDARS-SINAI MEDICAL CENTER CA $37,644
Pediatric Cancer 2017 NHLBI 1F31HL136107-01 Function of the Ubiquitin-Specific Peptidase 22 (USP22) in Acute Myeloid Leukemia MELO-CARDENAS, JOHANNA NORTHWESTERN UNIVERSITY AT CHICAGO IL $38,255
Pediatric Cancer 2017 NCI 5P01CA101937-14 7522 Genomics of AML Clonality LEY, TIMOTHY WASHINGTON UNIVERSITY MO $328,402
Pediatric Cancer 2017 NCI 5P01CA101937-14 7523 Genomics of AML Relapse DIPERSIO, JOHN WASHINGTON UNIVERSITY MO $330,341
Pediatric Cancer 2017 NCI 5P01CA101937-14 7524 Genomics of Familial MDS/AML GRAUBERT, TIMOTHY WASHINGTON UNIVERSITY MO $339,464
Pediatric Cancer 2017 NCI 5P01CA101937-14 7525 Genomics of Teatment-Related AML LINK, DANIEL WASHINGTON UNIVERSITY MO $334,581
Pediatric Cancer 2017 NCI 5P01CA101937-14 7526 Clinical Database WESTERVELT, PETER WASHINGTON UNIVERSITY MO $258,322
Pediatric Cancer 2017 NCI 5P01CA101937-14 7527 Specimen Acquisition, Genomic, Transcriptomic and Epigenetic Profilling PAYTON, JACQUELINE WASHINGTON UNIVERSITY MO $212,765
Pediatric Cancer 2017 NCI 5P01CA101937-14 7528 Sequencing and Integrated Analysis of AML Genomes WILSON, RICHARD WASHINGTON UNIVERSITY MO $986,260
Pediatric Cancer 2017 NCI 5P01CA101937-14 7529 Administration LEY, TIMOTHY WASHINGTON UNIVERSITY MO $127,287
Pediatric Cancer 2017 NCI 5R01CA129377-10 Plasminogen activator inhibitor-1 in tumor progression and metastasis DECLERCK, YVES CHILDREN'S HOSPITAL OF LOS ANGELES CA $239,246
Pediatric Cancer 2017 NCI 5R01CA124709-10 The Genetic Basis of Neuroblastoma Tumorigenesis MARIS, JOHN CHILDREN'S HOSP OF PHILADELPHIA PA $614,290
Pediatric Cancer 2017 NCI 1U01CA202947-01A1 Bench to bedside: non-invasive treatment of tumors in children KIM, PETER CHILDREN'S RESEARCH INSTITUTE DC $350,585
Pediatric Cancer 2017 NCI 5R01CA176803-03 Targeted- and timed-releasing nanotherapeutics against leukemia stem cells PAN, CHONG-XIAN UNIVERSITY OF CALIFORNIA AT DAVIS CA $359,138
Pediatric Cancer 2017 NCI 5R01CA185062-04 (PQB3) CD4 T cell response to BCR-ABL-positive Leukemia FARRAR, MICHAEL UNIVERSITY OF MINNESOTA MN $312,304
Pediatric Cancer 2017 NCI 5R01CA168622-05 Cell Fate Control by Integrated E2F, FoxO and PI3K Signaling in Retinoblastoma HALLSTROM, TIMOTHY UNIVERSITY OF MINNESOTA MN $315,400
Pediatric Cancer 2017 NCI 5R01CA193890-03 HAUSP inhibitors in p53-wild type and p53-mutant tumors GU, WEI COLUMBIA UNIVERSITY HEALTH SCIENCES NY $366,000
Pediatric Cancer 2017 NCI 5K99CA197640-02 Role of SNF5 in regulating SWI/SNF complex assembly & targeting in rhabdoid tumor WANG, XIAOFENG DANA-FARBER CANCER INST MA $151,649
Pediatric Cancer 2017 NIAID 1R21AI129426-01 Connecting Epigenetic Regulator MLL1 to ERK and Survival Signaling in B cells ERNST, PATRICIA UNIVERSITY OF COLORADO DENVER CO $228,355
Pediatric Cancer 2017 NCI 5K07CA200668-02 Patient Preferences and Adherence in Adolescents and Young Adults with Cancer MCGRADY, MEGHAN CINCINNATI CHILDRENS HOSP MED CTR OH $144,855
Pediatric Cancer 2017 NHLBI 5R01HL131444-02 The role of EVI1-induced hypermethylation in leukemogenesis. QIAN, ZHIJIAN UNIVERSITY OF ILLINOIS AT CHICAGO IL $399,750
Pediatric Cancer 2017 NCI 5R01CA175353-04 Deep sequencing for minimal residual disease detection in Acute Lymphoblastic Leu ROBINS, HARLAN FRED HUTCHINSON CANCER RESEARCH CENTER WA $648,389
Pediatric Cancer 2017 NCI 5R01CA174851-04 A longitudinal assessment of frailty in young adult survivors of childhood cancer NESS, KIRSTEN ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $538,152
Pediatric Cancer 2017 NHLBI 5R01HL052725-23 Molecular Pathogenesis of Fanconi Anemia D'ANDREA, ALAN DANA-FARBER CANCER INST MA $400,792
Pediatric Cancer 2017 NCI 5K08CA174750-04 Inhibiting STAT1 as a novel graft-versus-host/graft-versus-leukemia therapy CAPITINI, CHRISTIAN UNIVERSITY OF WISCONSIN-MADISON WI $178,740
Pediatric Cancer 2017 NCI 5F30CA196244-03 The role of the aryl hydrocarbon receptor in natural killer cell development in normal and acute myeloid leukemia donors SCOVILLE, STEVEN OHIO STATE UNIVERSITY OH $49,044
Pediatric Cancer 2017 NCI 5R01CA142928-08 Targeting the Kinome in Neurofibromatosis type 1 CHERNOFF, JONATHAN RESEARCH INST OF FOX CHASE CAN CTR PA $434,625
Pediatric Cancer 2017 NCI 5R01CA194923-03 Long non-coding RNAs in hematopoiesis and blood malignancy AIFANTIS, IANNIS NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $457,533
Pediatric Cancer 2017 NCI 5U54CA193419-03 7381 Project 2: Molecular Modulation of Chromatin and Nuclear Structure in Cancer LICHT, JONATHAN NORTHWESTERN UNIVERSITY AT CHICAGO IL $460,150
Pediatric Cancer 2017 NCI 5R03CA205311-02 Development of a mouse model of pediatric high-grade gliomas XIE, ZHIGANG TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR TX $74,250
Pediatric Cancer 2017 NCI 5R01CA178030-04 Regulation of transcription and tumor suppression by MTG family members HIEBERT, SCOTT VANDERBILT UNIVERSITY TN $364,000
Pediatric Cancer 2017 NCI 5R01CA185402-04 (PQD-5) Patient derived orthotopic xenograft models for drug response prediction LI, XIONAN BAYLOR COLLEGE OF MEDICINE TX $318,923
Pediatric Cancer 2017 NCI 5U54CA193461-03 7298 Project 1: Clonal Dynamics Guiding Curative Therapies for Acute Myeloid Leukemia SCADDEN, DAVID MASSACHUSETTS GENERAL HOSPITAL MA $532,795
Pediatric Cancer 2017 NIA 5R21AG052195-02 Screening for enhancers of sAPPalpha JOHN, VARGHESE UNIVERSITY OF CALIFORNIA LOS ANGELES CA $192,500
Pediatric Cancer 2017 NCI 5K08CA184419-02 Chemotherapy resistance induced by SETD2 loss in leukemia MAR, BRENTON DANA-FARBER CANCER INST MA $177,120
Pediatric Cancer 2017 NCI 5R01CA190509-03 The function of cyclin C in tumorigenesis SICINSKI, PETER DANA-FARBER CANCER INST MA $453,569
Pediatric Cancer 2017 NHLBI 5R01HL115145-05 Yes1 as a quiescence regulator in hematopoietic stem cells MUKHERJEE, SIDDHARTHA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $400,000
Pediatric Cancer 2017 NCI 5R25CA023944-34 PEDIATRIC ONCOLOGY EDUCATION (YEARS 33 - 37) GRONEMEYER, SUZANNE ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $321,271
Pediatric Cancer 2017 NCI 5K08CA181507-02 Analysis of TET2 function in acute leukemia SHIH, ALAN SLOAN-KETTERING INST CAN RESEARCH NY $180,036
Pediatric Cancer 2017 NCI 5K07CA166177-05 Bone Deficits and Excess Adiposity after Pediatric Bone Marrow Transplantation MOSTOUFI-MOAB, SOGOL CHILDREN'S HOSP OF PHILADELPHIA PA $164,862
Pediatric Cancer 2017 NCI 5R01CA175761-04 Function of the PR domain of the MDSI-EVI1 in MLL fusion protein leukemogenesis PERKINS, ARCHIBALD UNIVERSITY OF ROCHESTER NY $318,513
Pediatric Cancer 2017 NHLBI 5K08HL127269-03 Bone Marrow Microenvironmental Expression of Cytochrome P450 Enzymes GHIAUR, GABRIEL JOHNS HOPKINS UNIVERSITY MD $171,720
Pediatric Cancer 2017 NCI 5R01CA193776-03 Improving risk allocation and developing novel therapies for children with T-ALL TEACHEY, DAVID CHILDREN'S HOSP OF PHILADELPHIA PA $625,779
Pediatric Cancer 2017 NHLBI 5R01HL120724-03 Balanced signaling cues to guide cell transitions in the blood lineage continuum ROOSE, JEROEN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $742,879
Pediatric Cancer 2017 NCI 5R01CA194552-03 RETARGETING AGENTS TO TREAT AML DIPERSIO, JOHN WASHINGTON UNIVERSITY MO $380,068
Pediatric Cancer 2017 NCI 5R01CA197991-02 Determining the Role of Metabolism in Resistance in Acute Myeloid Leukemia PARDEE, TIMOTHY WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $354,563
Pediatric Cancer 2017 NHLBI 5R01HL079571-13 A Vital tool for the Study of DBA: The Diamond Blackfan Anemia Registry LIPTON, JEFFREY FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH NY $420,957
1234


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer